These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38428704)

  • 1. Biological activities, Molecular mechanisms, and Clinical application of Naringin in Metabolic syndrome.
    Chen J; Qin X; Chen M; Chen T; Chen Z; He B
    Pharmacol Res; 2024 Apr; 202():107124. PubMed ID: 38428704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.
    Alam MA; Subhan N; Rahman MM; Uddin SJ; Reza HM; Sarker SD
    Adv Nutr; 2014 Jul; 5(4):404-17. PubMed ID: 25022990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
    Massaro L; Raguzzini A; Aiello P; Valencia DV
    Endocr Metab Immune Disord Drug Targets; 2023; 23(4):428-445. PubMed ID: 36043734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evidence for the pharmacological actions of naringin: a review.
    Bharti S; Rani N; Krishnamurthy B; Arya DS
    Planta Med; 2014 Apr; 80(6):437-51. PubMed ID: 24710903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
    Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
    Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of naringin against drugs and chemical toxins induced hepatotoxicity: A review.
    Shirani K; Yousefsani BS; Shirani M; Karimi G
    Phytother Res; 2020 Aug; 34(8):1734-1744. PubMed ID: 32067280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms.
    Zhang X; Zhang Y; Gao W; Guo Z; Wang K; Liu S; Duan Z; Chen Y
    Life Sci; 2021 Jul; 277():119487. PubMed ID: 33862107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivity of naringin and related mechanisms.
    Zhao Y; Liu S
    Pharmazie; 2021 Aug; 76(8):359-363. PubMed ID: 34412734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
    Yang Y; Trevethan M; Wang S; Zhao L
    J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet.
    Pu P; Gao DM; Mohamed S; Chen J; Zhang J; Zhou XY; Zhou NJ; Xie J; Jiang H
    Arch Biochem Biophys; 2012 Feb; 518(1):61-70. PubMed ID: 22198281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
    Wat E; Wang Y; Chan K; Law HW; Koon CM; Lau KM; Leung PC; Yan C; Lau CBS
    Phytomedicine; 2018 Mar; 42():112-125. PubMed ID: 29655677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of naringin: an overview.
    Chen R; Qi QL; Wang MT; Li QY
    Pharm Biol; 2016 Dec; 54(12):3203-3210. PubMed ID: 27564838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naringin: Cardioprotective properties and safety profile in diabetes treatment.
    Yaseen HS; Zubair HM; Jamal A; Farrukh M; Mikrani R; Shaukat B; Hill JW; Rana R; Nazir A; Naveed M; Malik S
    Fitoterapia; 2024 Jul; 176():106011. PubMed ID: 38740344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.
    Nzuza S; Zondi S; Owira PMO
    PLoS One; 2017; 12(11):e0183355. PubMed ID: 29121676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
    Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
    Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD).
    Qiu YY; Zhang J; Zeng FY; Zhu YZ
    Pharmacol Res; 2023 Jun; 192():106786. PubMed ID: 37146924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.
    Guan L; Guo L; Zhang H; Liu H; Zhou W; Zhai Y; Yan X; Men X; Peng L
    Mol Nutr Food Res; 2024 Feb; 68(3):e2200812. PubMed ID: 38054638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging potential of citrus flavanones as an antioxidant in diabetes and its complications.
    Sharma M; Akhtar N; Sambhav K; Shete G; Bansal AK; Sharma SS
    Curr Top Med Chem; 2015; 15(2):187-95. PubMed ID: 25547100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review on the Pharmacokinetic Properties of Naringin and Its Therapeutic Efficacies in Respiratory Diseases.
    Zeng X; Su W; Liu B; Chai L; Shi R; Yao H
    Mini Rev Med Chem; 2020; 20(4):286-293. PubMed ID: 32134369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.